KalVista Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
11 Jun 2026	Form 4: Stuart Nancy, Director Disposed of 74,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Pereira Brian Jg, Director Disposed of 91,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Fairey William, Director Disposed of 57,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Audhya Paul K., CHIEF MEDICAL OFFICER Returned 150,260 shares to the issuer · Disposed of 125,800 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 202,500 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	Form 4: Sensenig Bethany, Director Disposed of 45,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Treanor Patrick, Director Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Sweeny Nicole, Chief Commercial Officer Returned 59,291 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 202,500 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	Form 4: Arif Bilal, Chief Operations Officer Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 49,000 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	Form 4: Reid Laurence, Director Disposed of 17,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Unkart Edward W, Director Disposed of 109,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2026	Form 4: Palleiko Benjamin L, Director Returned 479,989 shares to the issuer · Disposed of 666,035 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 777,999 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	Form 4: Yea Christopher, CHIEF DEVELOPMENT OFFICER Returned 229,918 shares to the issuer · Disposed of 343,920 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 66,250 Restricted Stock Unit (Disposition to Issuer)
11 Jun 2026	Form 4: Piekos Brian, Chief Financial Officer Returned 21,661 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 148,750 Restricted Stock Unit (Disposition to Issuer)
29 May 2026	Form 4: Yea Christopher, CHIEF DEVELOPMENT OFFICER Received 33,800 shares by exercise or conversion ($239K) · Sold 33,800 shares ($905K)
27 May 2026	Form 4: Yea Christopher, CHIEF DEVELOPMENT OFFICER Received 3,125 shares by exercise or conversion · Sold 1,966 shares ($52.6K)
27 May 2026	Form 4: Sweeny Nicole, Chief Commercial Officer Received 5,000 shares by exercise or conversion · Sold 1,489 shares ($39.9K)
27 May 2026	Form 4: Audhya Paul K., CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion · Sold 2,239 shares ($60K)
26 May 2026	Form 4: Palleiko Benjamin L, Director Received 23,250 shares by exercise or conversion · Sold 10,926 shares ($293K)
26 May 2026	Form 4: Sweeny Nicole, Chief Commercial Officer Received 6,250 shares by exercise or conversion · Sold 1,861 shares ($49.8K)
26 May 2026	Form 4: Yea Christopher, CHIEF DEVELOPMENT OFFICER Received 3,750 shares by exercise or conversion · Sold 2,358 shares ($63.2K)

Comments